TABLE 1 North America Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 2 North America Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 3 North America Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 4 North America Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 5 North America Mono Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 6 North America Mono Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 7 North America Combination Drug Therapy Market by Country, 2017 - 2020, USD Million
TABLE 8 North America Combination Drug Therapy Market by Country, 2021 - 2027, USD Million
TABLE 9 North America Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 10 North America Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 11 North America Alpha Blockers Market by Country, 2017 - 2020, USD Million
TABLE 12 North America Alpha Blockers Market by Country, 2021 - 2027, USD Million
TABLE 13 North America 5- alpha Reductase Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 14 North America 5- alpha Reductase Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Phosphodiesterase-5 Inhibitors Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Phosphodiesterase-5 Inhibitors Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Benign Prostatic Hyperplasia Therapeutics Market by Country, 2017 - 2020, USD Million
TABLE 20 North America Benign Prostatic Hyperplasia Therapeutics Market by Country, 2021 - 2027, USD Million
TABLE 21 US Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 22 US Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 23 US Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 24 US Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 25 US Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 26 US Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 27 Canada Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 28 Canada Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 29 Canada Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 30 Canada Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 31 Canada Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 32 Canada Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 33 Mexico Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 34 Mexico Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 35 Mexico Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 36 Mexico Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 37 Mexico Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 38 exico Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 39 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market, 2017 - 2020, USD Million
TABLE 40 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market, 2021 - 2027, USD Million
TABLE 41 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2017 - 2020, USD Million
TABLE 42 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market by Therapy, 2021 - 2027, USD Million
TABLE 43 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2017 - 2020, USD Million
TABLE 44 Rest of North America Benign Prostatic Hyperplasia Therapeutics Market by Therapeutics Class, 2021 - 2027, USD Million
TABLE 45 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 46 key information – Astellas Pharma, Inc.
TABLE 47 Key Information – Eli Lilly and Company
TABLE 48 Key Information – Allergan PLC
TABLE 49 key Information – Merck Group
TABLE 50 Key Information – Boehringer Ingelheim International GmbH
TABLE 51 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 52 Key Information – Sanofi S.A.
TABLE 53 Key Information – Pfizer, Inc.
TABLE 54 Key Information – Abbott Laboratories
List of Figures
FIG 1 Methodology for the research
Unique Offerings 